Alexandra Santana Sorensen

Title: The Innovative Contributions of Alexandra Santana Sorensen

Introduction

Alexandra Santana Sorensen is a prominent inventor based in Holte, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate important biological pathways. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

One of her latest patents is titled "Substituted 1,3-dioxanes useful as PPAR modulators." This invention describes specific stereoisomers of 1,3-dioxane derivatives and their applications in treating diseases dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders, and infections. Another notable patent is "Prodrugs of substituted 1,3-dioxanes and their uses." This invention relates to prodrugs of compounds containing a 1,3-dioxane moiety, along with pharmaceutical compositions and their applications in modulating thromboxane A2 or a peroxisome proliferator-activated receptor. These compounds can be utilized in the treatment and prevention of cancer.

Career Highlights

Alexandra works at Evolva SA, a company known for its innovative approaches in biotechnology. Her research and inventions have positioned her as a key figure in the development of new therapeutic options.

Collaborations

She collaborates with notable colleagues, including Peteris Alberts and Prathama Satyendra Mainkar, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Alexandra Santana Sorensen's innovative contributions to pharmaceutical science demonstrate her commitment to advancing medical treatments. Her patents reflect a deep understanding of complex biological mechanisms and a dedication to improving patient outcomes.